The Association of British HealthTech Industries (ABHI) and the University of Strathclyde have signed a Memorandum of Understanding (MoU), designed to stimulate innovation, research and product development in health technology in the Glasgow City Innovation District, for the benefit of UK and international patients.
The partnership will see a joint offering to UK and global healthcare technology companies, in medical devices, diagnostics and digital health, which will create an ideal triple helix between academics, industry and healthcare providers health.
Built around three priority areas of health technology research, investment and internationalization, future work will see ABHI and Strathclyde pooling their expertise to improve pathways to commercialization, bringing together investment communities. and innovation to explore challenges and solutions, with the aim of providing health systems with world-class health technologies.
Areas of collaboration that have already been identified include the early detection and diagnosis of chronic diseases and conditions.
Strathclyde, which was named Times Higher Education UK University of the Year 2019, is at the forefront of innovation in medicine and health technology. Through the activities of its Healthcare Technology Cluster, an industry-driven initiative, the University promotes the delivery of innovative technologies, enabling new treatments and models of care, emphasizing prevention and empowering people to live as well as possible at home and in their communities.
The role of the Strathclyde Institute of Medical Devices (SIMD) will be at the heart of the partnership with ABHI, securing its place as one of the main innovation hubs in Scotland and the UK.
Professor Sir Jim McDonald, Director and Vice-Chancellor of the University of Strathclyde, said: “The health technology and medical device sector has enormous potential to radically change healthcare, not only through the early detection and diagnosis of chronic diseases and conditions, but also giving individuals better control and management of their own health and well-being.
“Through our health technologies cluster, SIMD and our extensive Health and Care Futures activity, our goal is to use cutting-edge innovation and expertise in the fields of drug innovation, health technologies. health, data analytics and artificial intelligence, and the workforce and leadership to make an effective and sustainable contribution to the future of health and care in the UK and the -of the.
“This agreement with ABHI will allow us to explore opportunities to work together to support the research, development and commercialization of new health technologies. In doing so, we will help stimulate economic growth and job opportunities.
Healthtech plays a key role in supporting the delivery of healthcare and contributes significantly to the economic growth of the UK. Its main industry association in the UK is ABHI, which with over 320 members advocates for the use of safe and effective health technologies.
Peter Ellingworth, Managing Director of ABHI, said: “Scotland is home to a large and diverse healthcare technology industry that continues to grow. Institutions like the University of Strathclyde are an important factor in creating innovations in medical devices, diagnostics and digital health, which can benefit patients in Scotland, the UK and around the world. This partnership can help launch these innovations globally and raise the profile of the great work being done in Scotland. The Glasgow City Innovation district has an exciting offering, and we look forward to working together to further strengthen this ecosystem for the benefit of patients and drive the growth of the healthcare technology sector.